Entos Pharmaceuticals is developing a COVID-19 vaccine. Entos wishes to communicate and seek the federal government's support for a “made in Canada” solution to COVID-19.
John Lewis, Chief Executive Officer
End date of the last completed financial year: 2021-03-31
|Government Institution||Funding Received in Last Financial Year||Funding Expected in Current Financial Year|
|Innovation, Science and Economic Development Canada (ISED)||$10,000,000.00||Yes|
Unit 4550, 10230 Jasper Avenue
Edmonton, AB T5J 4P6
Entos Pharmaceuticals is not a subsidiary of any other parent companies.
Entos Pharmaceuticals does not have any subsidiaries that could have a direct interest in the outcome of the undertaking